Connect
MJA
MJA

Letters

Systematic postmarketing surveillance needed for misused psychoactive pharmaceutical drugs

Steven Moylan

Med J Aust 2013; 199 (11): 746-747

Epidemiology of tuberculosis and levels of vitamin D in Australia: person, place and time

Jennifer H MacLachlan and Benjamin C Cowie

Med J Aust 2013; 199 (10): 655-656

Dealing with disclosure in patients with borderline personality traits

Navin I Dadlani

Med J Aust 2013; 199 (10): 661

Liaise with pathologists to refine understanding of the prostate-specific antigen test

Kenneth A Sikaris, Bronwen A Ross and Teck Y Khong

Med J Aust 2013; 199 (10): 656-658

Re-treating bleeding hereditary haemorrhagic telangiectasia with bevacizumab

Gwo Yaw Ho, Edward Zhong and Boris Chern

Med J Aust 2013; 199 (10): 658

Sotalol-associated cardiogenic shock in a patient with asymptomatic transient rate-related cardiomyopathy

Simon D Leslie

Med J Aust 2013; 199 (10): 658-659

Immigration screening for latent tuberculosis infection

David W J Griffin and Mark D Kelly

Med J Aust 2013; 199 (10): 654

Amanita phalloides poisoning and treatment with silibinin in the Australian Capital Territory and New South Wales

Andrew J Pengilley and Paul M Kelly

Med J Aust 2013; 199 (10): 659-660

Immigration screening for latent tuberculosis infection

Justin T Denholm

Med J Aust 2013; 199 (10): 654

Reinforcing the iodine message for pregnant women in Australia

Karen E Charlton and Creswell J Eastman AM

Med J Aust 2013; 199 (10): 660

Think before you insert an intravenous catheter

Claire Dendle, Rhonda L Stuart and Diana Egerton-Warburton

Med J Aust 2013; 199 (10): 655

Psychotropic medication in pregnancy

Roisin N Worsley, Heather Gilbert and Jayashri Kulkarni

Med J Aust 2013; 199 (10): 661

Should we screen for lung cancer in Australia?

Henry M Marshall, Kwun M Fong and Rayleen V Bowman

Med J Aust 2013; 199 (9): 585-586

The dilemmas of prostate cancer screening

Paul R McKenzie, Brett Delahunt and James G Kench

Med J Aust 2013; 199 (9): 582

Should we screen for lung cancer in Australia?

Paul L R Mitchell and Thomas John

Med J Aust 2013; 199 (9): 586

The dilemmas of prostate cancer screening

Ian E Haines

Med J Aust 2013; 199 (9): 582-583

Should we screen for lung cancer in Australia?

Mark Hew, Robert G Stirling and Michael J Abramson

Med J Aust 2013; 199 (9): 586

The dilemmas of prostate cancer screening

Nathan Lawrentschuk, Declan G Murphy and Anthony J Costello

Med J Aust 2013; 199 (9): 583

The dilemmas of prostate cancer screening

Jonas Hugosson and Sigrid V Carlsson

Med J Aust 2013; 199 (9): 583-584

The dilemmas of prostate cancer screening

Chris B Del Mar*

Med J Aust 2013; 199 (9): 584

Prostate cancer screening

Mark Faigen

Med J Aust 2013; 199 (9): 585

The dilemmas of prostate cancer screening

George G Miklos

Med J Aust 2013; 199 (9): 582

Mental health consumer and carer participation: why we bother

Lydia C Trowse, Joanne G Cook and Tyson J A Clooney

Med J Aust 2013; 199 (3): S10 Free

Suicide risk assessment: where are we now?

Michael S Gordon and Glenn A Melvin

Med J Aust 2013; 199 (8): 534

Suicide risk assessment: where are we now?

Christopher J Ryan, Matthew M Large and Sascha Callaghan

Med J Aust 2013; 199 (8): 534